COVID-19 shots in the US are provided by Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX), Moderna (NASDAQ:MRNA) and Novavax (NASDAQ:NVAX).

In the most recent trading session, Novavax (NVAX) closed at $8.45, indicating a +0.24% shift from the previous trading day. Health and pharmaceutical stocks — including Moderna (MRNA), Pfizer ...

Novavax (NVAX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Novavax (NVAX) closed the most recent trading day at $8.45, moving +0.24% from the previous trading session. The stock trailed the S&P 500, which registered a daily gain of 0.72%. Meanwhile ...

Novavax shares are trading lower by 9.8% during Monday's session. Shares of vaccine stocks are trading lower after Moderna issued 2025 revenue guidance below analyst estimates. Next: Access Our ...

Novavax stock (NVAX) skyrocketed Friday ... While Novavax's vaccine did finally reach the market in mid-2022, targeting the booster market, it continued to struggle with $1.7 billion in ...

Brand New Membership Level: Benzinga Trade Alerts Novavax Inc NVAX shares dipped 11.2% to $9.60 during Wednesday’s session, pulling back following recent strength. Shares of vaccine makers are ...